Zobrazeno 1 - 10 of 82 pro vyhledávání: '"Budanov, O."'
1
Akademický článek
Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL.
Autor: Mikhailova E; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation katmikhailova1805@gmail.com., Popov A; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation., Roumiantseva J; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation., Budanov O; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation., Lagoyko S; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation., Zharikova L; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation., Miakova N; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation., Litvinov D; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation., Khachatryan L; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation., Pshonkin A; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation., Ponomareva N; Russian Children Clinical Hospital, Moscow, Russian Federation., Boichenko E; City Children's Hospital No 1, Saint Petersburg, Russian Federation., Varfolomeeva S; NN Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation., Dinikina J; Almazov National Medical Research Center, Saint Petersburg, Russian Federation., Novichkova G; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation., Henze G; Pediatric Hematology and Oncology, Ernst Moritz Arndt University Greifswald Faculty of Medicine, Greifswald, Mecklenburg-Vorpommern, Germany.; Pediatric Hematology and Oncology, Charite Medical Faculty Berlin, Berlin, Berlin, Germany., Karachunskiy A; Dmitry Rogachev National Medical Research Center of Pediatric Hematology Oncology and Immunology, Moscow, Russian Federation.
Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jun 06; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 06.
Zobrazit plný text záznamu
3
Akademický článek
Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.
Autor: Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Henze G; Department of Pediatric Oncology Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.; Ural State Medical University, Ekaterinburg, Russian Federation., Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Belevtsev M; Republican Scientific and Practical Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Movchan L; Republican Scientific and Practical Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Lagoyko S; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Zharikova L; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Olshanskaya Y; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Riger T; Regional Children's Hospital, Ekaterinburg, Russian Federation., Valochnik A; Republican Scientific and Practical Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Stolyarova E; Ural State Medical University, Ekaterinburg, Russian Federation., Ponomareva N; Pirogov Russian National Research Medical University, Moscow, Russian Federation., Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Aleinikova O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Publikováno v: Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (8), pp. e7172.
Zobrazit plný text záznamu
4
Akademický článek
One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study.
Autor: Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation. uralcytometry@gmail.com., Henze G; Department of Pediatric Oncology Hematology, Charité Universitätsmedizin Berlin, Berlin, Germany., Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation.; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Belevtsev M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Boyakova E; Moscow City Blood Center Named After OK Gavrilov, Moscow, Russian Federation., Movchan L; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Fadeeva M; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Lagoyko S; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Zharikova L; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Stolyarova E; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Ponomareva N; Republican Children's Hospital, Moscow, Russian Federation., Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Aleinikova O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation., Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, 1, S. Mashela st, Moscow, 117998, Russian Federation.
Publikováno v: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Jul; Vol. 149 (8), pp. 4629-4637. Date of Electronic Publication: 2022 Sep 28.
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
A simple procedure to identify children with B-lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single-point minimal residual disease measurement.
Autor: Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Belevtsev M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Boyakova E; Moscow City Blood Center named after OK Gavrilov, Moscow, Russian Federation., Movchan L; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Fadeeva M; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Lagoyko S; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Zharikova L; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Stolyarova E; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Ponomareva N; Republican Children's Hospital, Moscow, Russian Federation., Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Aleinikova O; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Jun; Vol. 70 (6), pp. e30295. Date of Electronic Publication: 2023 Mar 28.
Zobrazit plný text záznamu
7
Editorial & Opinion
Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008.
Autor: Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation. Electronic address: uralcytometry@gmail.com., Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Boyakova E; Moscow City Blood Center named after OK Gavrilov, Moscow, Russian Federation., Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Fadeeva M; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Lagoyko S; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Zharikova L; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Ponomareva N; Republican Children's Hospital, Moscow, Russian Federation., Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Publikováno v: Leukemia research [Leuk Res] 2023 Feb; Vol. 125, pp. 106998. Date of Electronic Publication: 2022 Dec 16.
Zobrazit plný text záznamu
8
Editorial & Opinion
A single flow cytometric MRD measurement in children with B-lineage acute lymphocytic leukemia and hyperleukocytosis redefines the requirements of high-risk treatment: Results of the study ALL-MB 2008.
Autor: Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation. Electronic address: uralcytometry@gmail.com., Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Belevtsev M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Boyakova E; Moscow City Blood Center named after OK Gavrilov, Moscow, Russian Federation., Movchan L; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Fadeeva M; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Lagoyko S; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Zharikova L; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Stolyarova E; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Ponomareva N; Republican Children's Hospital, Moscow, Russian Federation., Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Aleinikova O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Publikováno v: Leukemia research [Leuk Res] 2022 Dec; Vol. 123, pp. 106982. Date of Electronic Publication: 2022 Oct 22.
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Editorial & Opinion
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results.
Autor: Popov A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation. uralcytometry@gmail.com., Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany., Roumiantseva J; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Budanov O; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Belevtsev M; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Verzhbitskaya T; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Boyakova E; Moscow City Blood Center named after OK Gavrilov, Moscow, Russian Federation., Movchan L; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Tsaur G; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Fadeeva M; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Lagoyko S; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Zharikova L; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Miakova N; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Litvinov D; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Khlebnikova O; Regional Children's Hospital, Ekaterinburg, Russian Federation., Streneva O; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Stolyarova E; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus., Ponomareva N; Republican Children's Hospital, Moscow, Russian Federation., Novichkova G; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Fechina L; Regional Children's Hospital, Ekaterinburg, Russian Federation.; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation., Aleinikova O; Belarussian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus.; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Karachunskiy A; National Research and Clinical Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.
Publikováno v: Leukemia [Leukemia] 2022 May; Vol. 36 (5), pp. 1382-1385. Date of Electronic Publication: 2022 Mar 23.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje